This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: We aimed to determine whether there was a relationship between lifestyle factors and Alzheimer disease biomarkers.
Methods: In a cross-sectional study, we evaluated self-reported histories of recent and past cognitive activity, self-reported history of recent physical activity, and objective recent walking activity in 186 clinically normal individuals with mean age of 74 ± 6 years. Using backward elimination general linear models, we tested the hypotheses that greater cognitive or physical activity would be associated with lower Pittsburgh compound B–PET retention, greater 18F-fluorodeoxyglucose–PET metabolism, and larger hippocampal volume, as well as better cognitive performance on neuropsychological testing.
Results: Linear regression demonstrated that history of greater cognitive activity was correlated with greater estimated IQ and education, as well as better neuropsychological testing performance. Self-reported recent physical activity was related to objective exercise monitoring. However, contrary to hypotheses, we did not find evidence of an association of Pittsburgh compound B retention, 18F-fluorodeoxyglucose uptake, or hippocampal volume with past or current levels of cognitive activity, or with current physical activity.
Conclusions: We conclude that a history of lifelong cognitive activity may support better cognitive performance by a mechanism that is independent of brain β-amyloid burden, brain glucose metabolism, or hippocampal volume.
GLOSSARY
- Aβ=
- β-amyloid;
- AD=
- Alzheimer disease;
- AMNART=
- American version of the National Adult Reading Test;
- CA=
- cognitive activity;
- FDG=
- 18F-fluorodeoxyglucose;
- FS=
- FreeSurfer;
- GLM=
- general linear model;
- mcPiB=
- mean cortical Pittsburgh compound B;
- MP-RAGE=
- magnetization-prepared rapid-acquisition gradient echo;
- PiB=
- Pittsburgh compound B;
- PrecFDG=
- precuneus 18F-fluorodeoxyglucose;
- RelHippoVol=
- relative hippocampal volume;
- ROI=
- region of interest;
- TPASelf=
- self-reported total physical activity;
- TWAPed=
- pedometer-measured total walking activity;
- WalkSelf=
- self-reported walking activity
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received June 2, 2014.
- Accepted in final form March 10, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.